APA (7th ed.) Citation

Xu H, Wang W, Yin J, Song C, Li L, & Sun Z. (2022). Efficacy and Safety of the PD-1 Inhibitor Combined with Albumin-Bound Paclitaxel and Nedaplatin in Preoperative Neoadjuvant Therapy of Unresectable Stage III Lung Squamous Cell Carcinoma. Dove Medical Press.

Chicago Style (17th ed.) Citation

Xu H, Wang W, Yin J, Song C, Li L, and Sun Z. Efficacy and Safety of the PD-1 Inhibitor Combined with Albumin-Bound Paclitaxel and Nedaplatin in Preoperative Neoadjuvant Therapy of Unresectable Stage III Lung Squamous Cell Carcinoma. Dove Medical Press, 2022.

MLA (9th ed.) Citation

Xu H, et al. Efficacy and Safety of the PD-1 Inhibitor Combined with Albumin-Bound Paclitaxel and Nedaplatin in Preoperative Neoadjuvant Therapy of Unresectable Stage III Lung Squamous Cell Carcinoma. Dove Medical Press, 2022.